Unconfigured Ad

Collapse

Discussion of next-gen sequencing related bioinformatics: resources, algorithms, open source efforts, etc

Forums Topics Posts Last Post
No forums found.
  •  
  • Time
  • Answered
  • Show
  • New Topics
Clear All
new posts
There are no conversations in this channel.
 
  • Time
  • Show
Clear All
new posts
Please log in to your account to view your subscribed posts.
  •  
  • Time
  • Answered
  • Show
  • Sort By
  • Order
Clear All
new posts
Topics Statistics Last Post
Started by laura, 05-09-2011, 04:42 AM
35 responses
107,908 views
0 reactions
Last Post laura
by laura
 
Started by sci_guy, 01-23-2008, 11:19 PM
236 responses
687,178 views
1 reaction
Last Post ECO
by ECO
 
Started by dongshong, 02-20-2011, 08:55 PM
0 responses
1,622 views
0 reactions
Last Post dongshong  
Started by Pejman, 11-10-2010, 12:21 PM
1 response
2,890 views
0 reactions
Last Post Boel
by Boel
 
Started by Lien, 02-14-2011, 06:08 AM
3 responses
2,942 views
0 reactions
Last Post Lien
by Lien
 
Started by tgenahmet, 05-05-2009, 12:07 PM
8 responses
15,679 views
0 reactions
Last Post lingfung.tang  
Started by gprakhar, 02-18-2011, 12:40 PM
2 responses
3,882 views
0 reactions
Last Post gprakhar  
Started by biobee07, 02-18-2011, 07:59 AM
1 response
1,926 views
0 reactions
Last Post dariober  
Started by rcorbett, 02-16-2011, 08:27 AM
5 responses
4,705 views
0 reactions
Last Post Michael.James.Clark  
Started by bio, 06-02-2010, 08:06 AM
2 responses
2,305 views
0 reactions
Last Post rstarke
by rstarke
 
Started by ylc, 02-18-2011, 09:53 AM
0 responses
2,335 views
0 reactions
Last Post ylc
by ylc
 
Started by Marius, 02-17-2011, 08:14 AM
3 responses
4,079 views
0 reactions
Last Post simonandrews  
No topics found.
  • Time
Clear All
No photos found.
  • Time
Clear All

Webinars

Collapse

Recent Articles

Collapse

  • SEQadmin2
    How Immunogenomics Decodes Immunity’s Genetic Blueprint
    by SEQadmin2




    The immune system’s power comes from its genetic diversity, allowing myriad threats to be neutralized through first recognizing foreign antigens. That diversity is also what makes the immune system so difficult to study. Recent advances in sequencing technology and computational biology, however, are giving researchers new tools to understand immune responses and immune-related diseases in greater detail.

    This convergence of genetics, immunology, and computation...
    09-01-2026, 05:41 AM
  • SEQadmin2
    Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
    by SEQadmin2



    CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

    Despite this, “CRISPR helped turn genome editing from a specialized technique into
    ...
    07-31-2026, 11:01 AM
  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 09-09-2026, 12:14 PM
0 responses
16 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 09-09-2026, 11:33 AM
0 responses
13 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 09-03-2026, 10:22 AM
0 responses
27 views
0 reactions
Last Post SEQadmin2  
Working...